|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Blepharitis |
|
Blepharoconjunctivitis |
|
Conjunctivitis, infectious |
|
Dacryocystitis |
|
Infection, ophthalmic |
|
Keratitis |
|
Keratoconjunctivitis |
|
Ulcer, corneal |
| |
|
|
SIDE EFFECTS:
|
|
Allergic reaction or Hypersensitivity |
|
Conjunctivitis |
|
Corneal ulcers, bacterial or fungal |
|
Hallucinations |
|
Thrombocytopenia |
|
Burning or stinging |
|
Blurred vision |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
|
|
ADULT DOSE:
|
|
Antibacterial (ophthalmic)-Topical, to the conjunctiva, a thin strip (approximately 1 cm) of ointment to the affected eye every eight to twelve hours. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
See Usual adult and adolescent dose.
Neonates-Safety and efficacy have not been established. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|